TrialNature communications2022
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Javier Martin-Broto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialNature communications2022
Javier Martin-Broto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.